The largest database of trusted experimental protocols

Multiplate 5.0 analyzer

Manufactured by Diapharma

The Multiplate 5.0 Analyzer is a laboratory instrument designed for the assessment of platelet function. It measures the aggregation of platelets in response to various agonists, providing information about the platelet's ability to form clots. The analyzer utilizes multiple electrode aggregometry technology to analyze platelet reactivity.

Automatically generated - may contain errors

Lab products found in correlation

4 protocols using multiplate 5.0 analyzer

1

Multiplate Platelet Aggregation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the multiple channel electrical impedance platelet aggregometry (Multiplate 5.0 Analyzer, Diapharma Group Inc), heparinized blood samples were kept at room temperature and analyzed within 40 minutes of blood collection (range, 29–40 minutes) for 12 minutes. Before each analysis, the test cells were warmed to 37°C within the aggregometer and an automated pipette was used to decrease preanalytical variability. Heparinized blood samples (300 µL) were diluted with 300 µL of diluent and incubated for 3 minutes as recommended by the manufacturer (Multiplate 5.0 Analyzer, Diapharma Group Inc). Adenosine diphosphate (ADP; Diapharma Group Inc, West Chester, Ohio) and arachidonic acid (AA; Diapharma Group Inc) were used as platelet agonists and area under the curve (AUC) for ADP (AUCADP) and for AA (AUCAA) were recorded. Note that the AUC value is an arbitrary unit. As recommended by the manufacturer (Multiplate 5.0 Analyzer, Diapharma Group Inc), the final concentration of ADP was 6.5 µM and the final concentration of AA was 0.5 mM. To serve as a control and to evaluate for spontaneous platelet aggregation, an identical volume of saline was used in place of the agonists (AUCsaline). The reagents were reconstituted and stored according to the manufacturer's recommendations (Diapharma Group Inc) in 60 µL aliquots.
+ Open protocol
+ Expand
2

Platelet Aggregation Assay with NO Donors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Whole venous blood was used to measure platelet aggregation, diluted 1:1 in isotonic sodium chloride with 3 mM sodium citrate. A Multiplate 5.0 Analyzer from diaPharma was used for platelet aggregation studies. Aggregation was induced by ADP (1 μM) after preincubation with NO donors (all at 1 μM final concentration) for five minutes. All these procedures were carried out at 37 °C.
+ Open protocol
+ Expand
3

Platelet Aggregometry in Whole Blood

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fresh whole blood at T0, T2, T72 and T96 time points was placed in a 2.7 ml vacutainer containing 3.2% citrate, allowed to rest 30 min at room temperature, after which platelet aggregometry was measured on a Multiplate 5.0 Analyzer (Diapharma, West Chester, Ohio) according to manufacturer’s instructions [32 (link)]. Specifically, 300 μl of carefully mixed whole blood was incubated with 300 μl saline, or saline with 2 mM calcium chloride for 3 minutes in a test cell at 37⁰C with continuous mixing; agonist was then added and the aggregometry determined over a six minute assay. Agonists and their final concentrations were: ADP, 6.5 μM; collagen, 3.2 μg/ml; thrombin receptor activating peptide (TRAP), 32 μM; arachidonic acid (ASPI), 0.5 mM and ristocetin, 0.77 mg/ml.
+ Open protocol
+ Expand
4

Electrical Impedance Platelet Aggregation

Check if the same lab product or an alternative is used in the 5 most similar protocols
For multiple channel electrical impedance PA (Multiplate 5.0 Analyzer, Diapharma Group Inc, West Chester, Ohio), heparinized blood samples were kept at room temperature and analyzed within 32 minutes of blood collection for 12 minutes. Before analysis, test cells were warmed to 37°C in the aggregometer and an automated pipette was utilized. Heparinized blood samples (300 μL) were diluted with 300 μL 0.9% NaCl and incubated for 3 minutes. Adenosine diphosphate (ADP) and arachidonic acid (AA; Diapharma Group Inc) were used as platelet agonists and area under the curve (AUC) for ADP (AUCADP) and for AA (AUCAA) was recorded (PA for ADP and AA were performed in duplicate). The AUC value is an arbitrary unit. As recommended by the manufacturer (Diapharma Group Inc), final concentration of ADP was 6.5 μM and final concentration of AA was 0.5 mM. To serve as a control with no agonist added, an identical volume of saline was used in place of the agonists (AUCsaline). Reagents were reconstituted and stored in 60 μL aliquots according to the manufacturer's recommendations (Diapharma Group Inc). The test was repeated if any quality control flags were observed for ADP, AA, or saline.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!